Skip to content
Homepage
Author:
X4 Pharmaceuticals
Posted Date:
September 9, 2026
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
X4 Pharmaceuticals
September 9, 2026
X4 Pharmaceuticals: FDA Agrees to Reduced Sample Size for Chronic Neutropenia Trial
X4 Pharmaceuticals
September 8, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals
September 1, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals
July 7, 2026
